IBDEI2HK ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,39697,2)
;;=^5002392
;;^UTILITY(U,$J,358.3,39698,0)
;;=D47.Z9^^152^2000^178
;;^UTILITY(U,$J,358.3,39698,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39698,1,3,0)
;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
;;^UTILITY(U,$J,358.3,39698,1,4,0)
;;=4^D47.Z9
;;^UTILITY(U,$J,358.3,39698,2)
;;=^5002262
;;^UTILITY(U,$J,358.3,39699,0)
;;=D05.82^^152^2000^35
;;^UTILITY(U,$J,358.3,39699,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39699,1,3,0)
;;=3^Carcinoma in Situ Left Breast,Other Spec Type
;;^UTILITY(U,$J,358.3,39699,1,4,0)
;;=4^D05.82
;;^UTILITY(U,$J,358.3,39699,2)
;;=^5001934
;;^UTILITY(U,$J,358.3,39700,0)
;;=D05.81^^152^2000^37
;;^UTILITY(U,$J,358.3,39700,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39700,1,3,0)
;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
;;^UTILITY(U,$J,358.3,39700,1,4,0)
;;=4^D05.81
;;^UTILITY(U,$J,358.3,39700,2)
;;=^5001933
;;^UTILITY(U,$J,358.3,39701,0)
;;=D05.80^^152^2000^39
;;^UTILITY(U,$J,358.3,39701,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39701,1,3,0)
;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
;;^UTILITY(U,$J,358.3,39701,1,4,0)
;;=4^D05.80
;;^UTILITY(U,$J,358.3,39701,2)
;;=^5001932
;;^UTILITY(U,$J,358.3,39702,0)
;;=D56.8^^152^2000^191
;;^UTILITY(U,$J,358.3,39702,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39702,1,3,0)
;;=3^Thalassemias,Other
;;^UTILITY(U,$J,358.3,39702,1,4,0)
;;=4^D56.8
;;^UTILITY(U,$J,358.3,39702,2)
;;=^5002305
;;^UTILITY(U,$J,358.3,39703,0)
;;=C82.89^^152^2000^77
;;^UTILITY(U,$J,358.3,39703,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39703,1,3,0)
;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
;;^UTILITY(U,$J,358.3,39703,1,4,0)
;;=4^C82.89
;;^UTILITY(U,$J,358.3,39703,2)
;;=^5001540
;;^UTILITY(U,$J,358.3,39704,0)
;;=D51.8^^152^2000^198
;;^UTILITY(U,$J,358.3,39704,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39704,1,3,0)
;;=3^Vitamin B12 Deficiency Anemias,Other
;;^UTILITY(U,$J,358.3,39704,1,4,0)
;;=4^D51.8
;;^UTILITY(U,$J,358.3,39704,2)
;;=^5002288
;;^UTILITY(U,$J,358.3,39705,0)
;;=I80.9^^152^2000^183
;;^UTILITY(U,$J,358.3,39705,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39705,1,3,0)
;;=3^Phlebitis/Thrombophlebitis,Unspec Site
;;^UTILITY(U,$J,358.3,39705,1,4,0)
;;=4^I80.9
;;^UTILITY(U,$J,358.3,39705,2)
;;=^93357
;;^UTILITY(U,$J,358.3,39706,0)
;;=D45.^^152^2000^184
;;^UTILITY(U,$J,358.3,39706,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39706,1,3,0)
;;=3^Polycythemia Vera
;;^UTILITY(U,$J,358.3,39706,1,4,0)
;;=4^D45.
;;^UTILITY(U,$J,358.3,39706,2)
;;=^96105
;;^UTILITY(U,$J,358.3,39707,0)
;;=C77.3^^152^2000^113
;;^UTILITY(U,$J,358.3,39707,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39707,1,3,0)
;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
;;^UTILITY(U,$J,358.3,39707,1,4,0)
;;=4^C77.3
;;^UTILITY(U,$J,358.3,39707,2)
;;=^5001330
;;^UTILITY(U,$J,358.3,39708,0)
;;=C77.2^^152^2000^129
;;^UTILITY(U,$J,358.3,39708,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39708,1,3,0)
;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
;;^UTILITY(U,$J,358.3,39708,1,4,0)
;;=4^C77.2
;;^UTILITY(U,$J,358.3,39708,2)
;;=^267316
;;^UTILITY(U,$J,358.3,39709,0)
;;=C77.1^^152^2000^130
;;^UTILITY(U,$J,358.3,39709,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,39709,1,3,0)
;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2HK 3784 printed Apr 09, 2024@21:16:53 Page 2
IBDEI2HK ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,39697,2)
+2 ;;=^5002392
+3 ;;^UTILITY(U,$J,358.3,39698,0)
+4 ;;=D47.Z9^^152^2000^178
+5 ;;^UTILITY(U,$J,358.3,39698,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,39698,1,3,0)
+8 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
+9 ;;^UTILITY(U,$J,358.3,39698,1,4,0)
+10 ;;=4^D47.Z9
+11 ;;^UTILITY(U,$J,358.3,39698,2)
+12 ;;=^5002262
+13 ;;^UTILITY(U,$J,358.3,39699,0)
+14 ;;=D05.82^^152^2000^35
+15 ;;^UTILITY(U,$J,358.3,39699,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,39699,1,3,0)
+18 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
+19 ;;^UTILITY(U,$J,358.3,39699,1,4,0)
+20 ;;=4^D05.82
+21 ;;^UTILITY(U,$J,358.3,39699,2)
+22 ;;=^5001934
+23 ;;^UTILITY(U,$J,358.3,39700,0)
+24 ;;=D05.81^^152^2000^37
+25 ;;^UTILITY(U,$J,358.3,39700,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,39700,1,3,0)
+28 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
+29 ;;^UTILITY(U,$J,358.3,39700,1,4,0)
+30 ;;=4^D05.81
+31 ;;^UTILITY(U,$J,358.3,39700,2)
+32 ;;=^5001933
+33 ;;^UTILITY(U,$J,358.3,39701,0)
+34 ;;=D05.80^^152^2000^39
+35 ;;^UTILITY(U,$J,358.3,39701,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,39701,1,3,0)
+38 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
+39 ;;^UTILITY(U,$J,358.3,39701,1,4,0)
+40 ;;=4^D05.80
+41 ;;^UTILITY(U,$J,358.3,39701,2)
+42 ;;=^5001932
+43 ;;^UTILITY(U,$J,358.3,39702,0)
+44 ;;=D56.8^^152^2000^191
+45 ;;^UTILITY(U,$J,358.3,39702,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,39702,1,3,0)
+48 ;;=3^Thalassemias,Other
+49 ;;^UTILITY(U,$J,358.3,39702,1,4,0)
+50 ;;=4^D56.8
+51 ;;^UTILITY(U,$J,358.3,39702,2)
+52 ;;=^5002305
+53 ;;^UTILITY(U,$J,358.3,39703,0)
+54 ;;=C82.89^^152^2000^77
+55 ;;^UTILITY(U,$J,358.3,39703,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,39703,1,3,0)
+58 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
+59 ;;^UTILITY(U,$J,358.3,39703,1,4,0)
+60 ;;=4^C82.89
+61 ;;^UTILITY(U,$J,358.3,39703,2)
+62 ;;=^5001540
+63 ;;^UTILITY(U,$J,358.3,39704,0)
+64 ;;=D51.8^^152^2000^198
+65 ;;^UTILITY(U,$J,358.3,39704,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,39704,1,3,0)
+68 ;;=3^Vitamin B12 Deficiency Anemias,Other
+69 ;;^UTILITY(U,$J,358.3,39704,1,4,0)
+70 ;;=4^D51.8
+71 ;;^UTILITY(U,$J,358.3,39704,2)
+72 ;;=^5002288
+73 ;;^UTILITY(U,$J,358.3,39705,0)
+74 ;;=I80.9^^152^2000^183
+75 ;;^UTILITY(U,$J,358.3,39705,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,39705,1,3,0)
+78 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
+79 ;;^UTILITY(U,$J,358.3,39705,1,4,0)
+80 ;;=4^I80.9
+81 ;;^UTILITY(U,$J,358.3,39705,2)
+82 ;;=^93357
+83 ;;^UTILITY(U,$J,358.3,39706,0)
+84 ;;=D45.^^152^2000^184
+85 ;;^UTILITY(U,$J,358.3,39706,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,39706,1,3,0)
+88 ;;=3^Polycythemia Vera
+89 ;;^UTILITY(U,$J,358.3,39706,1,4,0)
+90 ;;=4^D45.
+91 ;;^UTILITY(U,$J,358.3,39706,2)
+92 ;;=^96105
+93 ;;^UTILITY(U,$J,358.3,39707,0)
+94 ;;=C77.3^^152^2000^113
+95 ;;^UTILITY(U,$J,358.3,39707,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,39707,1,3,0)
+98 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
+99 ;;^UTILITY(U,$J,358.3,39707,1,4,0)
+100 ;;=4^C77.3
+101 ;;^UTILITY(U,$J,358.3,39707,2)
+102 ;;=^5001330
+103 ;;^UTILITY(U,$J,358.3,39708,0)
+104 ;;=C77.2^^152^2000^129
+105 ;;^UTILITY(U,$J,358.3,39708,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,39708,1,3,0)
+108 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
+109 ;;^UTILITY(U,$J,358.3,39708,1,4,0)
+110 ;;=4^C77.2
+111 ;;^UTILITY(U,$J,358.3,39708,2)
+112 ;;=^267316
+113 ;;^UTILITY(U,$J,358.3,39709,0)
+114 ;;=C77.1^^152^2000^130
+115 ;;^UTILITY(U,$J,358.3,39709,1,0)
+116 ;;=^358.31IA^4^2
+117 ;;^UTILITY(U,$J,358.3,39709,1,3,0)
+118 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
